>> Continued From the Previous Page <<
In total, Bayer has already shelled out over $10 billion in settlements — and 67,000 lawsuits are still active across the United States.
From Industry King to Corporate Roadkill
The financial carnage tells a story of arrogance, greed, and denial.
Since acquiring Monsanto for $63 billion in 2018, Bayer’s stock has collapsed more than 70%. Once Germany’s most valuable publicly traded company, it’s now worth less than the debt it carries.
Bayer’s market capitalization — about $25.6 billion — is actually smaller than its €33.3 billion debt load. That means every pending lawsuit is now worth almost $400,000 on paper.
Even Bayer’s CEO Bill Anderson has admitted that the company “barely breaks even on glyphosate production” and loses “$2 billion to $3 billion a year” factoring in legal costs.
The company made $2.8 billion in glyphosate sales last year — but those profits are wiped out by courtroom disasters.
Shareholders are so furious that Bayer may issue new stock worth 35% of its current market cap just to raise settlement cash.
Bayer’s Desperate Options: End Roundup or Go Bankrupt
Facing an unending wave of lawsuits, Anderson is considering a nuclear option: stop making glyphosate entirely.
“We’re pretty much reaching the end of the road,” he told The Wall Street Journal. “We’re talking months, not years.”
Bayer has reportedly told U.S. lawmakers that it could cease Roundup sales unless it receives legal immunity from Congress.
That would be a global earthquake. Bayer manufactures 40% of the world’s glyphosate supply, meaning an immediate production halt would wipe out nearly half of global capacity.
Sources told Bloomberg the company has even floated putting Monsanto into bankruptcy protection — using a controversial “Texas Two-Step” tactic that splits its assets and liabilities to limit payouts.
The Smoking Gun: Monsanto’s Secret Knowledge
The tipping point for juries came when internal documents — the infamous Monsanto Papers — showed executives knew for decades about potential cancer risks but concealed the data.
Emails revealed “amicable relationships with regulators” and efforts to suppress studies linking glyphosate to cancer.
Those revelations made juries furious. As one Georgia verdict noted, Monsanto “acted with conscious disregard for safety,” after evidence showed the company “downplayed cancer risks while aggressively marketing the product.”
This wasn’t a case of ignorance — it was a cover-up.
The Fall of the Chemical Farming Cartel
If Bayer collapses, it could mark the end of a corrupt agricultural empire built on chemical dependency.
For decades, Monsanto’s “Roundup Ready” genetically modified crops locked farmers into an endless cycle: buy their seeds, buy their chemicals, or watch your farm fail.
The soil itself became addicted to their poison.
Now the walls are closing in — and the illusion of control is shattering.
But there’s a dark twist: the same elites who protected Bayer are already building their next empire. They’re pushing “AI-driven farming,” “synthetic biology,” and “climate-smart” pesticides — all dressed up as innovation but designed to tighten control even further.
Real Farming Is Fighting Back
The bright side? The farmers who rejected Monsanto years ago are thriving.
Small growers, organic ranchers, and old-school farmers are proving that you don’t need Bayer’s chemicals to feed the world.
If Bayer truly falls, it will be the first time in decades that a chemical giant paid the price for poisoning the planet.
But justice won’t be complete until the system that built Bayer’s empire is exposed — and dismantled.
Because the real battle isn’t just against one corporation.
It’s against the machine that keeps reinventing the same poison — with a new name and a shinier label.
